Authors

• Giuseppe Curigliano (ORCID: https://orcid.org/0000-0003-1781-2518)
• Shigehisa Kitano (ORCID: https://orcid.org/0000-0002-4041-8298)
• Kohei Shitara (ORCID: https://orcid.org/0000-0001-5196-3630)
• Matteo Simonelli (ORCID: https://orcid.org/0000-0002-5264-1251)
• Ramón Yarza (ORCID: https://orcid.org/0000-0002-5885-0820)
• David Berz (ORCID: https://orcid.org/0000-0001-8368-4601)
• Izuma Nakayama (ORCID: https://orcid.org/0000-0003-4987-1934)
• Daniel Acosta Eyzaguirre
• Min Yan (ORCID: https://orcid.org/0000-0002-3911-748X)
• Ting Deng (ORCID: https://orcid.org/0000-0003-4552-8039)
• Sara A. Hurvitz (ORCID: https://orcid.org/0000-0001-7808-7191)
• Daniela Maier
• Xian Wang (ORCID: https://orcid.org/0000-0003-0041-7589)
• Qingyuan Zhang (ORCID: https://orcid.org/0000-0001-8116-5293)
• Gianluca Del Conte (ORCID: https://orcid.org/0009-0000-0481-953X)
• Damijan Eržen
• Sila Aykut Yazgili
• Bernard Gaston Doger de Speville Uribe

Institutions

• Hebron University (PS)
• Boehringer Ingelheim (Germany) (DE)
• Humanitas University (IT)
• Vita-Salute San Raffaele University (IT)
• Harbin Medical University (CN)
• University of Milan (IT)
• University of Washington (US)
• Sir Run Run Shaw Hospital (CN)
• Tianjin Medical University Cancer Institute and Hospital (CN)
• Zhengzhou University (CN)
• Star Technology and Research (United States) (US)
• Third Affiliated Hospital of Harbin Medical University (CN)
• Henan Cancer Hospital (CN)
• National Cancer Center Hospital East (JP)
• Istituti di Ricovero e Cura a Carattere Scientifico (IT)
• IRCCS Humanitas Research Hospital (IT)
• Japanese Foundation For Cancer Research (JP)
• Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
• European Institute of Oncology (IT)
• Zhejiang University (CN)

Publication Details

Journal

Future Oncology

Published

2025-10-17

DOI

https://doi.org/10.1080/14796694.2025.2569553

Citations

2

Primary Topic

HER2/EGFR in Cancer Research

Type

article

Field-Weighted Citation Impact

2.09